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“In summary, there are no small problems. Problems that appear small are large 
problems that are not understood. Nature is a harmonious mechanism where all parts, 
including those appearing to play a secondary role, cooperate in the functional whole. No 
one can predict their importance in the future. All natural arrangements, however 
capricious they may seem, have a function.” 
 
-Santiago Ramón y Cajal, 1897 

  
ABSTRACT 
This thesis is focused on several aspects of neural crest biology, largely related to two 
main issues: 1) understanding its mechanisms of migration and 2) analyzing the 
potential of neural crest stem cells or their derivatives for nervous system repair. If 
repair is the aim, knowledge of both timing and events leading to axonal degeneration 
is required in order to block it and/or increase regeneration outcome. In these studies I 
have made use of mouse, rat and chicken in vivo and in vitro models to address specific 
questions regarding the scope of this thesis. 
In paper I, changes in distribution of myelin proteins are described after ligation of the 
sciatic nerve, an injury model which does not allow nerve regeneration to occur. 
Clustering of MBPs and P0 (the two most abundant peripheral myelin proteins) was 
shown to precede their degradation, involving subsequent roles of Schwann cells (SCs) 
and macrophages in the removal of debris distally to the injury zone. Both clustering 
and protein degradation steps were found to be accelerated in young rat animals when 
compared to adult ones. 
In paper II, similar kind of studies were applied in other two injury models allowing 
regeneration to occur: a transient compression (crush) of the nerve or an intraneural 
injection of colchicine, which transiently blocks axonal transport. Changes in 
distribution of myelin (MBPs) and axonal (PGP9.5) protein immunoreactivities were 
monitored for up to one month and degeneration/regeneration processes followed and 
compared in the two models. By applying the trophic factor apotransferrin we were 
able to block the degeneration produced by colchicine, likely through stabilization of 
axonal and/or SC cytoskeleton. 
In paper III, original culture protocols have been applied to efficiently generate highly 
pure cultures of mature SCs from boundary cap neural crest stem cells (bNCSCs). The 
in vitro SC differentiation from stem cells was found to resemble the in vivo process 
when looking at combinations of markers changing expression during SC lineage. Stem 
cell-derived SCs were able to myelinate axons both in vitro and in vivo. These results 
prompted further work shown in paper V, in which the regenerative potential of neural 
crest stem cell-derived SCs has been tested in the contused spinal cord injury model. 
Even though in most cases grafted cells died soon after transplantation, when grafted 
alive they were found to improve locomotor behavior and to enhance endogenous 
regenerative mechanisms, producing both an increase in axonal re-growth and in 
recruitment of endogenous glial cells. In this study, evidences are shown suggesting 
that after injury ependymal cells of the spinal cord central canal can generate 
endogenous glial cells of myelinating phenotype, likely including some of the Schwann 
like cells which populate the injury zone allowing axonal re-growth. 
In paper IV, the scaffolding protein Nedd9 is shown to be expressed by multipotent 
migrating and post-migratory neural crest cells (NCCs). Nedd9 expression is induced in 
NCCs at the level of the dermamyotome dorsal lip. Loss-of-function and gain-of-
function studies were consistent with a principal role for Nedd9 in NCC migration. 
Retinoic acid, known to be synthesized by the dermamyotome, was found to induce 
Nedd9 expression in NCCs. Nedd9 expression pattern in mouse is described in paper 
VI, including mesencephalic ventral midbrain as well as other discrete progenitor 
populations from diverse tissues and organs. 
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1 INTRODUCTION 
 
The aim of this thesis has been to increase our knowledge of neural crest development 
while trying new strategies for repairing the nervous system. Therefore, it was built at 
the interface between two leading edge biomedical research fields: Developmental 
Biology and Regenerative Medicine. A prove for that is the establishment at the 
Karolinska Institute of its probably two top inter-departmental research centers of these 
years, the Center of Excellence in Developmental Biology (CEDB) and the subsequent 
Center of Excellence in Developmental Biology for Regenerative Medicine (DBRM) 
which I got the fortune to participate in. 
Developmental Biology is devoted to study how organisms form and grow, aiming to 
uncover all different cellular and molecular aspects involved in the emergence of 
diverse biological structures from a single cell stage to the complex organization found 
in an adult individual. This discipline has originated from the classical Experimental 
Embryology and highly evolved thanks to the emergence and developments achieved 
in Molecular Biology. It includes all aspects of embryonic development (Embryology) 
but also adds new areas of interest like how organs are regenerated, post-embryonic 
growth (i.e. metamorphosis, aging) and evolutionary aspects of developmental 
mechanisms. It aims to study a broad spectrum of processes from large scale events, as 
morphogenetic changes, to mechanisms at the molecular level driving cell proliferation, 
differentiation or death, which are often involved in organogenesis. In this field, the 
neural crest (NC) is a good model system for studying several developmental features 
like patterning, directed migration, determination and differentiation (Le Douarin and 
Kalcheim, 1999).        
Nervous system repair, within the Regenerative Medicine area, aims to promote 
recovery after injury. The two main strategies in use to achieve repair consist in: 1) 
reducing secondary damage due to tissue inflammation, and 2) increasing regeneration, 
by either cell grafting or enhancement of endogenously occurring mechanisms, which 
results in replacement of tissue in the injury zone and axonal regrowth.    
 
 
1.1 THE NEURAL CREST 
 
1.1.1 Origin and general aspects 
The development of the NC is one of the most relevant events in vertebrates and it 
favored their evolutionary successful emergence and irradiation (Glenn Northcutt, 
2005). The main property of the NC is their high motility which allows it to populate 
very distant tissues. The NC is of principal importance since they contribute to the 
formation of many organs/tissues such as peripheral nervous system (generating 
derivatives such as neurons and glia), heart, blood vessels, bone, ear, eyes, skin, teeth, 
meninges, skeletal muscle and adrenal gland. Some connective tissue components of 
pituitary, lachrymal, salivary, thyroid and parathyroid glands, and thymus are also NC 
derived (reviewed by Le Douarin and Kalcheim, 1999). After gastrulation, the NC 
originates from the neural folds and/or the dorsal neural tube in which cells are induced 
to differentially express proteins driving their epithelial-to-mesenchymal transition 
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(EMT) and detachment from the neural primordium (delamination). For NC induction 
both competence of the ectoderm to respond to a neural inducer from the mesoderm 
(Albers, 1987; Mancilla and Mayor, 1996) and interaction of the neural plate with the 
non-neural ectoderm (Rollhauser ter Horst, 1979; Moury and Jacobson, 1989, 1990) are 
required. Regulation of BMP4 expression by signals derived from developing somites 
and Wnt signaling activation are involved in cell delamination (Sela-Donenfeld and 
Kalcheim, 2000; Burstyn-Cohen et al., 2004; Taneyhill and Bronner-Fraser, 2005; 
Shoval et al., 2007). Immediately after delamination, NCCs start migrating either 
ventrally close to the neural tube or dorso-laterally in proximity to the somatic 
ectoderm (future skin) (Weston, 1963; Keynes and Stern, 1984; Erickson and Perris, 
1993). By largely unknown mechanisms which may depend on their progenitor state, 
NCCs stop migrating and subsequently differentiate into a variety of cell types.  
Some NCCs eventually stop migrating at prospective dorsal and ventral root entry zone 
levels and become clustered forming the boundary cap. These transient structures were 
found to be the source of late migrating NCCs shown by lineage tracing to at least 
produce glial cells and nociceptive sensory neurons in vivo (Maro et al., 2004). 
 
 
1.1.2 Methods for studying the neural crest 
The neural crest was first described in chicken by His in 1868 (Hall, 1999). Classical 
embryology techniques early used to address contribution of NC to tissues/organs 
consisted in the removal of neural folds, before NC emigration and subsequent analyses 
of structures that were lacking in those organisms (reviewed by Hörstadius, 1950 and 
Weston, 1970). In order to establish NC fate maps, several intrinsic and extrinsic 
molecular markers were used. In amphibian embryos, NCs were identified by 
cytoplasmic inclusions (Landacre, 1921; Stone, 1932), nuclear staining properties 
(Milaire, 1959), and cell size differences (Raven, 1937). Le Douarin (1973) has taken 
advantage of quail nuclear markers to distinguish NCC from chick counterparts and 
was able to construct NC fate maps in xenografts: antibodies recognizing quail nuclear 
specific epitopes (monoclonal anti-QPNC, quail non-chick perinuclear antigen, DSHB) 
were developed afterwards. Other intrinsic markers used were acetylcholinesterase (for 
identification of presumptive NC within the neuroepithelium; Cochard and Coltey, 
1983) and later on, with the emergence of monoclonal antibodies technology, the 
HNK-1/NC-1 epitope, which is expressed in avian NC progenitors after delamination 
and in some neural (Vincent and Thiery, 1984) and skin (Erickson et al., 1992; Nataf et 
al., 1993) lineages. Other antibodies used for NCC identification are: Sox10 (which 
strongly labels multipotent NCCs but is also expressed by peripheral glia progenitors 
and oligodendrocytes; Wegner and Stolt, 2005), Sox2 (which weakly labels NCCs at 
DRG borders; Wakamatsu et al., 2004), endothelin receptor 3 (EDN3; known to be 
required for skin pigmentation and gut innervation; Baynash et al., 1994), platelet-
derived growth factor receptor alpha (PDGFRα; in cephalic NCCs; Soriano, 1997; 
Hoch and Soriano, 2003), c-ret (already expressed prior to NCC emigration; Pachnis et 
al., 1993), p75 (which labels all NCC pathways; Stemple and Anderson, 1992; 
Bannerman and Pleasure, 1993; Rifkin et al., 2000) and TrkC (for ventrally migrating 
NCCs but not in melanocytes; Kahane and Kalcheim 1994; Henion et al., 1995; Rifkin 
et al., 2000).  
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The use of extrinsic markers opened the possibility to perform NCC potential analyses. 
First experiments were done by labeling entire embryos and grafting neural folds in 
unlabeled embryos (Detwiler, 1937) but lack of specificity and cytotoxicity were 
among concerns raised against those experiments. The development of vital dyes like 
DiI (1-1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate, Molecular 
Probes), applied either by injection into the neural tube lumen (Serbedzija et al., 1989; 
1990) or deposited on cells (Lumsden et al., 1991), permitted more accurate results.  
For clonal analyses of single cells different approaches were taken which mainly 
consisted in application of two different methods: 1) iontophoretic injection of tracer 
and 2) radiotonic labeling with tritiated thymidine (Weston, 1963). As example of 
tracer, lysinated rhodamine dextran (LRD; Gimlich and Braun, 1985) has being 
frequently used in avian neural crest studies (Bronner-Fraser and Fraser, 1988; 1989; 
Fraser and Bronner-Fraser, 1991; Artinger et al., 1995). A draw-back of these methods 
is that the labeling gets diluted through cell proliferation. Frank and Sannes (1991) 
made use of in vivo retroviral infection of lacZ which has the advantage of targeting 
cells in a random manner and of not getting diluted in progeny since the provirus is 
heritable; however, the probability of infecting more than one cell while using this 
technique is higher than in tracer injection experimental approach.  
First observations of migration of neural crest from neural tube explants were reported 
by Dorris (1936), in chick. This allowed the performance of further in vitro studies on 
isolated NCCs. Potential of these cells was addressed through two alternative systems: 
1) in vivo lineage tracing and 2) in vitro cloning. In vivo approach is indicative of NC 
potential but it does not give the answer of the entire potential of each individual cell. 
In vitro approach is permissive to study all potentialities of each individual cell as 
determined by the spectrum of different cell types it could generate. In vitro models 
used were: 1) single cell cultures (Baroffio et al., 1988 and 1991; Dupin et al., 1990; 
Dupin and Le Douarin, 1995; made on feeder layer), 2) low density of cell populations 
(Cohen and Königsberg, 1975; Sieber-Blum and Cohen, 1980; Stemple and Anderson, 
1992), and 3) labeling of individual cells of a population (Henion and Weston, 1997).  
As for other research fields, mouse genetic approach made possible to uncovered 
several aspects of neural crest biology. The Ret conditional knockout made by Luo et 
al. (2007) confirmed the requirement for this receptor tyrosine kinase in the migration 
of prospective gut NCCs from the dorsal aorta (Pachnis et al. 1993) and in the 
formation of the enteric nervous system (Durbec et al., 1996; Natarajan et al., 2002). It 
has also shown that Wnt1 gene is activated in all neural crest derived cells of the DRG 
and sympathetic ganglia which normally express Ret. Both Noggin and Chordin 
knockouts were instrumental to address in vivo differential requirements for both BMP 
antagonists in neural crest formation and migration (Anderson et al., 2006). FoxS1 
knockout mice even though presenting a very mild phenotype (Heglind et al., 2005) 
were instrumental to uncover mechanisms of early sensory neurogenesis (Montelius et 
al., 2007). In vivo models for several human pathologies were made by ablating 
relevant genes functional in neural crest (Wegner and Stolt, 2005). For example, 
conditional deletion of TGFβ receptor type II upon Wnt1 gene activation was able to 
reproduce several features of the Di George syndrome such as cleft palate, craniofacial 
dysmorphism, hypoplastic or undetectable parathyroid and thymus glands, and multiple 
cardiovascular deficiencies due to lack of neural crest-derived smooth muscle cells, 
likely involving TGFβ signaling components in this human syndrome (Wurdak et al., 
2005). Specific requirements for Sox9 and Sox10 expression in NC development were 
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also addressed using mouse genetics (Britsch et al., 2001; Cheung et al., 2005). NCCs 
die after delamination in Sox9 deficient mice and they were found to only lack from 
Snail expression while other NC markers are normally expressed (Cheung et al., 2005). 
Slug/Snail were reported to confer resistance to cell death (Vega et al., 2004), and this 
may provide NCCs capacity for long-distance migration. 
An alternative approach for addressing in vivo functional role of specific proteins 
consists in electroporating chick embryos in ovo. It can complement mouse genetic 
models and even serve to address function of certain proteins having highly 
homologous paralogs, given that knockout mice very often present mild or absent 
phenotypes due to functional redundancy. The roles of Sox9, RhoB, FoxD3 and 
Snail/Slug in neural crest EMT and delamination have been addressed by Cheung et al. 
(2005) using this approach. In this very same article, electroporation of FoxD3 
construct was shown to: 1) induce Sox10, which in turn initiates HNK-1, and 2) down-
regulate N-Cadherins and induce β1 integrin expression in a SoxE independent manner. 
The role played by Sox10 in the acquisition of neural crest identity and function was 
studied by McKeown et al. (2005), using chick electroporation model. 
In ovo electroporation was also instrumental to visualized NCC migratory behavior in 
whole embryo explants (Teddy and Kulesa, 2004; Kasemeier-Kulesa et al., 2005): 
NCCs migrate in chain-like formations and show frequent cell-cell interactions likely 
involving directional guidance cues.   
 
 
1.1.3 Neural crest motility 
NC migration through different pathways depends on the development of somites and it 
is especially related to the epithelial-mesenchymal conversion of this structure (Loring 
and Erickson, 1987; Teillet et al., 1987). NCCs start entering the somites at the levels 
corresponding to 5th to 9th somites, rostrally to the more recently formed somite 
(Erickson and Perris, 1993). At stage HH15 approximately 65% of NCCs are 
transversing the rostral sclerotome in chick (Lallier and Bronner-Fraser, 1988). 
Interestingly, NCCs wait at the staging area (close to the dorsal border of the somite) 
until the dermamyotome is formed and then progress along the dermamyotome basal 
lamina, but when they reach its lateral regions lacking from basal lamina depart from 
the myotome surface and migrate down through the sclerotome (Tosney et al., 1994). 
In mouse, it is known from DiI studies (done by neural tube intraluminal injections at 
E8.5-E10; Serbedzija et al., 1990) that NCC emigration starts at E8.5. The early 
migration of NCCs takes place at E8.5-E9.5 and those cells give rise to dorsal aorta and 
sympathetic ganglia. A second wave of NCCs occurs at E9-E10 and those cells mostly 
reach the DRG anlage.  
The subectodermal/dorsolateral pathway of NCCs is delayed one day in chicken 
(Serbedzija et al., 1989; 1990; Erickson et al., 1992), maybe due to transient 
extracellular matrix (ECM) inhibition likely involving ephrinB ligands (Oakley et al., 
1994) and/or to the requirement for previous NCC specification into a melanocytic 
lineage (Erickson and Goins, 1995; Santiago and Erickson, 2002). Slit1-3 were 
reported to be expressed in the mesenchyme surrounding the aorta and gut, and trunk 
but not vagal NCCs express Robo1 and 2, suggesting that they may block ventral 
migration of trunk NCCs (De Bellard et al., 2003). As suggested by previous reports, a 
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major role in migration of NCCs is played by short-range signals, mostly through 
inhibition, which differently affect them according to their cell intrinsic properties.  
NCCs depend on the availability of adequate extracellular matrix along pathways and 
on locally expressed ligands and their receptors to migrate. While injection of 
antibodies against fibronectin, laminin-heparan sulfate proteoglycans complex or 
tenascin in cranial NCCs blocks their migration, they do not seem to affect trunk NCCs 
(Bronner-Fraser, 1986; Bronner-Fraser and Lallier, 1988); nevertheless, it was reported 
that antibodies against α4 integrins significantly reduce trunk neural crest migration 
capacity but not delamination (Testaz and Duband, 2001). В1-integrins, transmembrane 
receptors known to bind all of ECM molecules mentioned above, are found widespread 
in NCCs (Duband et al., 1986; Le Douarin and Kalcheim, 1999). Tucker (2004) has 
shown that electroporation of a β1-integrin morpholino antisense oligo causes defects in 
NCC delamination while migration of targeted cells seemed not to be largely affected. 
No major defects in NCC migration were found in knock-out mice when specific 
individual integrins were deleted (reviewed by Perris, 1997).  
A right balance adhesion-detachment seems to be crucial for NCC delamination and 
migration (Gurniak et al., 2005) and it is regulated by calcium at the extracellular side 
of the membrane (Monier-Gavelle and Duband, 1997). Integrin functions in NC 
development consist in: 1) providing physical anchorage for cell motion; 2) promoting 
actin assembly to generate tension via focal complexes (Geiger et al., 2001), and 3) 
engaging several tyrosine kinases and GTPases which induce diverse signaling 
pathways, largely unknown for NCCs (Giancotti and Ruoslahti, 1999; DeMali et al., 
2003). Integrins were shown to cooperate with growth factor receptors (ffrench-
Constant and Colognato, 2004) and are thought to regulate cell-cell interactions 
established via cadherins (Monier-Gavelle and Duband, 1997). Intercellular junctions 
mediated by cadherins (Bronner-Fraser et al., 1992; Monier-Gavelle and Duband, 
1995) and N-CAM (Akitaya and Bronner-Fraser, 1992) are still present at neural fold 
fusion stage but disappear about 5 hours before onset of migration (Newgreen and 
Gibbins, 1982). Subsets of NCCs were shown to migrate interconnected through their 
processes by cadherins (Nakagawa and Takeichi, 1995). Cadherin 7 is expressed by 
NCCs and it does not likely mediate strong cell-cell contacts or interfere with NCC 
migration (Dufour et al., 1999). Cadherins were shown to be required for NCC 
migration (Xu et al., 2001). 
In the trunk, ventral NCC migration follows segmental patterns and it is restricted to the 
anterior half of the somite, in association with permissive ECM signals (Krull, 2001; 
Gammill et al., 2006). Fibronectin was early found to be one of such signals (Thiery et 
al., 1982), since it is expressed in vivo in NCC migratory pathways (Duband et al., 
1986), and it (or its RGDS constitutive fragment alone) promotes cell attachment, 
spreading and dispersion in vitro (Rovasio et al., 1983; Dufour et al., 1988; Perris et al., 
1989). Ephrin ligands (Krull et al., 1997; Wang and Anderson, 1997) and semaphorin 
3F (Gammill et al., 2006) and their receptors were shown to determine segmental 
migration through inhibitory mechanisms.    
Motility of NCC was reported to be accelerated by TGF-β1 and 2 (Delannet and 
Duband, 1992). TGF-β induces Slug expression (Duband et al., 1995), and Slug was 
involved in NCC EMT since Slug antisense oligonucleotides caused its failure (Nieto et 
al., 1994). Hepatocyte growth factor/Scatter factor (SF/HGF) and its receptor (c-met) 
may also be involved in NCC EMT and/or migration. There is overlapping expression 
of both SF/HGF and c-met in murine NCC (Andermarcher et al., 1996) and HGF over-
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expression causes skin hyperpigmentation (Takayama et al., 1996). However, its 
deletion has no apparent phenotype in NCCs (Schmidt et al., 1995). The chemokine 
stromal cell-derived factor-1 (SDF-1) was shown to regulate migration and to be 
chemoattractant for trunk NCCs (Belmadani et al., 2005).   
A role for Pax3 was also described in NC emigration from the neural tube (Moase and 
Trasler, 1990) and NC formation was shown to be severely affected in Pax3 mouse 
mutants (Splotch mutants; Serbedzija and McMahon, 1997). Interestingly, the latter 
study indirectly showed that a successful migration of NCCs requires the interaction 
between those cells and the somites and that molecules involved in mechanisms 
mediating that interaction are lacking in the Splotch mutation. Retinoic acid, of somite 
origin, was found to regulate Pax3 as well as Wnt1, Wnt3a, BMP4 and Msx2 in dorsal 
neural tube and/or neural crest of quail embryos at relevant developmental stages, 
suggesting a role for retinoids in neural crest EMT, delamination and migration 
(Wilson et al., 2004). Wnt signals are implicated in NCC migration as suggested by 
migratory deficiency and blocked cell-matrix adhesion when cells were treated with 
LiCl, an inhibitor of GSK-3, or co-cultured with Wnt1-expressing feeder cells (de 
Melker et al., 2004). 
Mechanisms involved in cessation of migration are largely unknown. In Sema-3A 
deficient mouse embryos, sympathetic precursors do not coalesce into ganglia; 
however, when those progenitors were exposed to Sema-3A in vitro they clustered and 
emitted neurites (Kawasaki et al., 2002). Shh was reported to inactivate integrins, 
blocking NCC migration (Testaz et al., 2001).         
 
 
1.1.4 Potential and heterogeneity   
As shown by cloning and individual cell labeling experiments, early migrating neural 
crest consists in a heterogeneous population including multipotent (generating cells of 
all or many NCC cell lineages), oligopotent (generating few or at least two different 
cell lineages) and neuronally-lineage restricted progenitors which may respond to 
different signals to migrate (reviewed by Le Douarin and Kalcheim, 1999).  
From in vitro clonal studies, the NCCs were found to consist on approximately 80% of 
multipotent/oligopotent progenitors (Baroffio et al., 1991; Dupin and Le Douarin, 
1995). Henion and Weston (1997) found that 44.5% of NCCs that leave the neural tube 
were monopotent committed precursors just few hours after explanting. In this model, 
restriction in potential was found to be progressive with time of incubation: at 13-16 
hours, 52.2% of NCCs were lineage restricted and this population increased to 77% at 
30-36 hours. It still remains unclear which model reflects better the potential of 
individual NCCs. 
In vivo lineage tracing experiments in avian and amphibian embryos resulted in that the 
majority of NCCs gives rise to cells of multiple lineages in different organs and within 
each organ (Bronner-Fraser and Fraser, 1989; Frank and Sanes, 1991). Unfortunately, 
in those studies the identity of cells in each organ was not determined by use of specific 
cell markers.    
Although a major fraction of NCCs in vivo are multipotent and are likely dispersed 
within pathways (Le Douarin and Kalcheim, 1999), over-expression of c-myc in NCCs 
is followed by preferential migration through the ventral pathway and further neuronal 
differentiation (Wakamatsu et al., 1997) suggesting a directional migration for sub-
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populations of NCCs being defined by fate determination. There is still lack of 
sufficient markers to establish the potential capacity of individual migrating NCCs but 
much have been improved. 
Several factors expressed in the dorsal neural tube may already specify some NCCs 
before delamination (reviewed by Dorsky et al., 2000). Wnt1 and Wnt3a have being 
implicated in melanocyte specification and/or expansion (Ikeya et al., 1997; Dorsky et 
al., 1998; Jin et al. 2001; Dunn et al., 2005) as well as sensory neurogenesis (Hari et 
al., 2002; Lee et al., 2004). BMPs and other TGFβ signaling pathways may also be 
involved in NC specification before emigration (Dorsky et al., 2000). 
In addition, NCCs have been shown to present a high degree of plasticity and once 
differentiated they were found to reverse their phenotype to a multipotent stage or to 
transdifferentiate (Le Douarin and Dupin, 2003; Real et al., 2006). Adult peripheral 
glial cells have been reported to generate pigment cells after severe peripheral nerve 
injury in mouse (Rizvi et al., 2002).  
 
 
1.1.5 Neural crest stem cells  
A commonly used definition of a stem cell require the fulfillments of the two following 
conditions: 1) capacity to generate an identical daughter cell (cell renewal) and 2) to 
give rise to cells more restricted in potential (differentiation). According to this criteria, 
it has been suggested that a small proportion of NCCs are pluripotent (giving rise to all 
neural crest derivatives) and self-renew (1-3%) and the great majority of them likely 
consist in progenitors of different potential capacity (Crane and Trainor, 2006). In 
mammals, neural crest stem cells were first isolated from trunk neural tube explants by 
flow-cytometry (Stemple and Anderson, 1992): these cells were shown to self renew 
and to be able to differentiate and therefore deserve the name of NCSCs. Afterwards, 
they were obtained from embryonic sciatic nerve (Morrison et al., 1999) and 
mandibular processes (Zhang et al., 2006), postnatal gut (Kruger et al., 2002), and adult 
skin (Sieber-Blum et al., 2004), cardiac tissue (Tomita et al., 2005) and cornea 
(Yoshida et al., 2006). In avian, two different bipotent precursor cells were shown to 
self renew in vitro and to produce glia and melanocytes or glia and myofibroblasts 
(Trentin et al., 2004). The boundary cap has been reported to contain stem cells able to 
self-renew and to generate at least three different lineages in the trunk neural crest 
progeny (Hjerling-Leffler et al., 2005). NC stem cells are promising tools for cell based 
therapy. 
 
 
 
1.2 NERVOUS SYSTEM REPAIR 
 
1.2.1 Wallerian degeneration and nervous system regeneration. 
Peripheral sensory and autonomic neurons reside in metameric structures called ganglia 
and send projections (axons) to innervate their target tissues. Those neuronal 
projections are included in structures called nerves in association with glial cells 
(named as SCs) which are important in diverse neuronal physiological and systemic 
processes, including isolation of axons and enhancement of transmission speed of 
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electric impulses through neuronal projections. SCs produce myelin, a structure derived 
from deposition of several layers of cell membrane produced by their turning around 
axons, consisting therefore mainly in lipids and proteins. Thickness of myelin sheath is 
regulated by neuregulin (NRG) levels in the axons to which SCs interact with, it is 
directly proportional to axonal caliber and the larger the axons are the faster the 
conduction of nervous impulses is (Michailov et al., 2004; Willem et al., 2006). 
In the Peripheral Nervous System (PNS), myelin protein content consists in 20-30% of 
Myelin Basic Proteins (MBPs) (Garbay et al., 2000). It was suggested that fragments 
related to MBPs may triger SC proliferation after injury (Baichwal and DeVries, 1989; 
Tzeng et al., 1995, 1999). The MBP/P1 family of proteins is composed by 21.5, 18.5, 
17 and 14 KDa polypeptides produced by alternative splicing from the same 
evolutionary highly conserved gene sequence. MBP proteins are hydrophilic, localize 
to the cytoplasmic side of myelin membranes and are believed to contribute to myelin 
stabilization through formation of complex structures with negatively charged lipids 
(Martini et al., 1995). Other MBP, the P2, is present in minor amount than P1 isoforms 
18.5 and 21.5 KDa and is complementary to MBP/P1 in the interaction with lipids 
during compaction of myelin dense lines, but it is only expressed in a selected 
population of myelin fibers (Garbay et al., 2000).   
The P0, only found in peripheral myelin, represents 50-70% of its total protein content. 
It is an integral membrane 28KDa glycoprotein also involved in compaction and 
maintenance of the myelin sheath (Garbay et al., 2000).     
When a nerve or the spinal cord of an individual is injured, axons degenerate and 
myelin brakes-down distally to the lesion site in a process called Wallerian 
degeneration (Ramón y Cajal, 1928; Stoll et al., 2002). If a fast and efficient removal of 
debris takes place and signals and physical support promoting axonal re-growth are 
present, regeneration is allowed (Vargas and Barres, 2007). These characteristics are 
fulfilled in the PNS, due to the cooperative action of both SCs, which start degrading 
myelin (Goodrum et al., 1994), and monocytes/macrophages, which rapidly invade, 
proliferate, produce growth factors and mitogens (inducing SC proliferation) and 
efficiently clean debris (Lindohlm et al., 1987; Baichwal et al., 1988; Fu and Gordon, 
1997; Matsuoka et al., 1997; Stoll and Muller, 1999). It was recently described that 
after injury SCs (identified by their S100 immunoreactivity) segregate their myelin 
content by forming ovoid structures within their cytoplasm (Hirata et al., 2000).  
In absence of axons, SCs establish an autocrine loop by production of insulin growth 
factor-1 (IGF-1), neurotrophins-3 (NT3) and platelet-derived growth factor-BB (PDGF-
BB), which makes them able to survive (Meier et al., 1999). SCs trigger axonal 
elongation through: 1) release of neurotrophins (i.e. nerve growth factor, NGF; brain-
derived growth factor, BDNF; glial-derived growth factor, GDNF), cytokines and 
leukemia inhibitory factor (LIF) (Matsuoka et al., 1997; Marcinkiewicz et al., 1999; 
Zhang et al., 2000; Hoke et al., 2002; Chen et al., 2007); 2) secretion of cell adhesion 
molecules (N-cadherins and ninjurin) promoting axonal growth (Ide C, 1996; Fu and 
Gordon, 1997; Luckenbill-Edds, 1997); 3) deposition of basal lamina while 
proliferating which results in formation of endoneural tubes (also known as SC tubes or 
"Bungner bands"), physically supporting axonal re-growth (Venstrom and Reichardt, 
1993; Ide C, 1996; Fu and Gordon, 1997). Finally, SCs may eventually contribute to 
redistribution and accumulation of Na+ and K+ channels in re-myelinated axons 
optimizing neuronal conduction properties (Joe and Angelides, 1992; Rasband et al., 
1998).   
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On the contrary, regeneration is very poor after central nervous system injury due to 
formation of glial scar, proliferation of cells non-permissive to axonal re-growth (which 
produce and release or expose inhibitory signals) and inefficient mechanisms of debris 
removal frequently leading to exacerbated inflammatory reactions causing secondary 
damage to the tissue. 
 
 
1.2.2 Trophic factors in maintenance of nervous system mature 
properties and regeneration. 
Trophic factors can be defined as substances stimulating growth, maintenance and 
survival of cells. It was shown that insults exclusively affecting SCs indirectly cause 
axonal degeneration (Angevine, 1957; Jacobs et al., 1972; Singer and Steinberg, 1972) 
and that axonal disintegration produces alterations in SC biology (Meier et al., 1999), 
arguing for the existence of a broad communication in between both cell types to keep 
mature nervous system tissue properties and function. Dependence on target-derived 
signals for peripheral neuron survival was concluded from limb ablation studies 
(Caldero et al., 1998). The first identified of these signals was Nerve Growth Factor 
(NGF; reviewed by Levi-Montalcini, 1987) and this finding opened the era of the 
developmental neurobiology. Other members of the “neurotrophin family” important 
for survival of specific neuronal populations were subsequently identified, including 
BDNF, NT-3 and NT-4/5 (Ernfors et al., 1994a; 1994b; Liu et al., 1995b). The first trk 
receptor was described by Martin-Zanca et al. (1986) but it was identified as receptor 
for NGF in 1991 (Kaplan et al., 1991; Klein et al., 1991). All neurotrophins share low 
affinity to the p75 NGF-receptor (Barker and Murphy, 1992). In last decades, 
neurotrophins physiological roles and signaling pathways have being extensively 
analyzed in development, maintenance and regeneration of the nervous system.  
A rapid and transient activation of ErbB2 (receptor for NRGs) has been reported to 
occur as early as 10 minutes after axotomy, distally to the injury zone, and this was 
sufficient to cause SC demyelination (Guertin et al., 2005). During development and 
after nerve injury or disease, axons respond to neurotrophins produced by SCs by 
releasing NRGs (Esper and Loeb, 2004), and reciprocally NRGs also influence glial 
neurotrophic factor expression (Verdi et al., 1996; Hansen et al., 2001). NRGs are 
required for Schwann cell lineage survival, proliferation, differentiation and maturation 
(reviewed by Jessen and Mirsky, 2005), even though NRG signaling mechanisms after 
injury may differ from those functional during development (Atanasoski et al., 2006). 
When axonal transport is blocked, the cell soma of peripheral neurons is deprived from 
neurotrophins and reacts to increase protein synthesis machinery and promote axonal 
re-growth. Several nerve injury models were developed to dismantle axonal 
cytoskeleton based on mechanical or chemical insults. A variety of chemical 
components are known to either block polymerization (as colchicine; Margolis and 
Wilson, 1977) or promote de-polymerization (Jordan et al., 1992) of microtubules 
which are the scaffold required for molecules (including growth factors) to move 
through axons. Several therapeutic interventions to either promote neuronal 
regeneration or block cell death induced by injury consist in the application of trophic 
factors (Muller and Stoll, 1998; Thoenen and Sendtner, 2002), however they have 
rendered contradictory results (Kanje et al., 1989; Gold, 1997; Munson and McMahon, 
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1997; Mohiuddin et al., 1999; Ramer et al., 2000; Boyd and Gordon, 2001; Markus et 
al., 2002). 
There is scientific evidence that the trophic factor transferrin (Mescher and Munaim, 
1988), a carrier of iron present in blood plasma, may promote nerve regeneration.  An 
increased in the endoneural uptake of iron has been described between 2 and 9 days 
after nerve injury together with up-regulation of transferrin receptor expression, which 
mediates the transport of saturated transferrin in macrophages and Schwann cells 
(Raivich et al., 1991; Hirata et al., 2000). Transferrin, as well as other proteins 
regulating iron levels, has also protective effects against excess of extracellular iron as 
well as against free radicals of nitric oxide (Aisen et al., 1999; Kaur and Ling, 1999). In 
the CNS, it is known that a single intracranial injection of apotransferrin (iron-free 
transferrin) into 3-day-old rats produces an increase in the myelination process 
(Escobar Cabrera et al., 1994, 1997) and that it stabilizes the microtubular network by 
increasing the mRNA levels of tubulin, actin and STOP (stable tubule only peptide) 
proteins (Cabrera et al., 2000). A holotransferrin transgenic mouse was made and its 
phenotypes in CNS are consistent with a role of this protein in inducing increased 
myelin protein synthesis and Sox10 and Olig1 expressions, overall suggesting a role for 
transferrin in oligodendrocyte maturation (Sow et al., 2006). Interestingly, during 
amphibian limb regeneration presence of axons in blastema is necessary for this process 
to occur (Geraudie and Singer, 1978; Brockes, 1987) and transferrin has been shown to 
be required for cell cycling as co-factor of the limiting enzyme for DNA synthesis 
(Seligman, 1983). In axolotls, by mean of classical experiments of double ligation of 
the sciatic nerve and prevention of axonal transport through application of colchicine in 
an in vitro multi-compartment system, transferrin was shown to undergo anterograde 
fast axonal transport (Kiffmeyer et al., 1991). Transferrin was reported to be released 
distally at growth cones (Meschner and Kiffmeyer, 1992) and its highest levels in 
sciatic nerves were found when axonal elongation was nearly complete and limb re-
differentiation underway (Kiffmeyer et al., 1991).  
Knowledge on molecules mediating neuron-glia interaction would likely allow the 
development of new strategies to increase regeneration outcome, decrease neuropathic 
pain and protect affected neurons from cell death. 
 
 
1.2.3 Schwann cells in nervous system repair 
Cells presenting SC properties were reported to populate the spinal cord after injury 
and axons were shown to grow in close apposition with these cells throughout the 
injury zone (Gilmore and Duncan, 1968; Harrison et al., 1975; Blakemore et al., 1977). 
Enhancement of these endogenous mechanisms was mediated by delivery of substances 
(Kaneko et al., 2006; Blesch and Tuszynski, 2007) and likely by cell grafting (Takami 
et al., 2002; Lu et al., 2006; Cao et al., 2007), with subsequent improvement of 
locomotor behavioral outcome. Given that SCs are a natural cell type in CNS after 
injury and that they promote axonal re-growth they are suitable candidates for cell 
replacement strategies after spinal cord injury. In fact, beneficial effects were 
abundantly reported after SCs grafting (Honmou et al., 1996; Oudega and Xu, 2006; 
Zujovic et al., 2007). Nevertheless, access to an adequate number of SCs is a limitation 
for their use in cell based therapy (Mimura et al., 2004) which may be eventually 
overcome by expanding a progenitor pool or stem cell population as a source of SCs. 
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1.3 NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY 
DOWN-REGULATED 9 (NEDD9) 
 
1.3.1 General description and discovery 
Nedd9, also known as HEF1 and Cas-L, is a member of the Cas family of scaffolding 
proteins described to be associated with cancer metastasis (Minn et al., 2005; Kim et 
al., 2006), immune system maturation (Seo et al., 2005), leukemia (de Jong et al., 
1997), arthritis (Iwata et al., 2005; Miyake-Nishijima et al., 2003) and stroke (Sasaki et 
al., 2005). It was first reported by Kumar et al. (1992) after performing subtraction 
cloning experiments with the aim of identifying cDNAs for genes highly expressed in 
the brain during development. In their publication, Kumar and collaborators have 
described the 3’ untranslated region of Nedd9 protein. First complete descriptions of 
Nedd9 appeared in 1996: published by two independent research groups. One of them 
named it as HEF1 (Human Enhancer of Filamentation 1), because of the described 
capacity of its C-terminal domain to induce filamentous yeast budding in S. cerevisiae, 
a property likely related to cell polarization and cell cycle (Law et al., 1996). HEF1 was 
described to localize in focal adhesions and to associate with FAK and the Abl kinase 
(Law et al., 1996). Minegishi et al. (1996), while trying to clone the gene encoding a 
protein known to be phosphorylated on tyrosines upon ligation of β1 integrins in T 
cells, described the same molecule with the name Cas-L (for Crk-associated substrate-
related protein, lymphocyte type). The Cas-L protein was also shown to bind FAK and 
to additionally interact with other integrin effectors like Crk, Nck and SHPTP2 upon 
adhesion through integrins (Minegishi et al., 1996). 
 
 
1.3.2 Protein structure, localization and function 
 Nedd9 has several interaction domains, similar to its two mammalian paralog family 
members: p130Cas/BCAR1 (Sakai et al., 1994) and Efs/Sin (Ishino et al., 1995; 
Alexandropoulos and Baltimore, 1996; Alexandropoulos et al., 2003). Only one 
member of the Cas family of proteins was found in Drosophila (Huang et al., 2007). 
P130Cas was the first Cas protein described in this family, found to be abundantly 
expressed in almost all cell lines and tissues and functionally related to cell adhesion 
and migration (reviewed by Defilippi et al., 2006). Expression of both Nedd9 and 
Efs/Sin are widespread during embryogenesis but gets restricted to few tissues in adult 
organisms, and their function is less well known than for p130Cas (Singh et al., 2007). 
Nedd9 contains an N-terminal SH3 domain (aa 10-65 in humans; binding to proteins 
containing poly-proline motif), a domain with large number of SH2 binding sites (aa 
90-350 in humans; with several tyrosines; named as “substrate domain”), a domain 
with large number of serine residues (aa 350-650 in humans) and the C-terminal 
domain, highly conserved among Cas proteins (Singh et al., 2007). This C-terminal 
domain may interact with other helix-loop-helix (HLH) proteins and allow homo-
/hetero-dimerization of Cas proteins (Law et al., 1999). Interestingly, p130Cas and 
Efs/Sin but not Nedd9 contain poly-proline residues which make them able to interact 
with SH3 domains. Nedd9 and p130Cas present DLDV and DDYD caspase cleavage 
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sites (Law et al., 2000; Kook et al., 2000); however, induction of apoptosis mediated 
by p130Cas was not reported. Both Nedd9 terminal domains were found to interact 
with Smad3 (the effector of TGFβ signaling) for protein degradation which suggest a 
rapid turn-over of this protein (Liu et al., 2000; Nourry et al., 2004).  
Nedd9 was described as cytoplasmic but it concentrates in focal adhesions (upon cell 
adhesiveness to substrate; Law et al., 1996) or in the centrosome or mitotic spindle 
(during mitosis; Law et al., 1998). Nedd9 structure and sub-cellular localization suggest 
its involvement in cell adhesion and migration, apoptosis and cell cycle.  
Nedd9 full-length over-expression increases cell spreading (Fashena et al., 2002) while 
forced expression of the Nedd9 C-terminal region results in cell detachment and 
rounding (O’Neill and Golemis, 2001). Requirement of Nedd9 for migration was 
shown in glioblastoma (Natarajan et al., 2006) and lymphocytes (Ohashi et al., 1999) 
and consistently while Nedd9 over-expression promotes cell motility (Fashena et al., 
2002) its down-regulation impairs chemotactic responses (Seo et al., 2005), the latter 
likely through Nedd9 function as component of GPCR signaling pathways (Zhang et 
al. 1999). Signaling through Nedd9 in promotion of cell migration seems to involve 
phosphorylation mediated by FAK/Src and subsequent interaction with Crk (Minegishi 
et al., 1996; van Seventer et al., 2001; Fashena et al., 2002; Natarajan et al., 2006) 
which may lead to GTPase Rac and/or Rap1 activation (Cai et al., 2003b; Tamada et 
al., 2004). Alternative signaling pathways may involve interaction with BCAR3/AND-
34/SHEP2/Nsp2 and Chat and regulation of Cdc42 activation (Sakakibara and Hattori, 
2000; Cai et al., 2003a; Regelmann et al., 2006). Rho kinase inhibition (Bargon et al., 
2005) and FAK knock-down (van Seventer et al., 2001; Kim et al., 2006) have been 
reported to block Nedd9-induced increase migration and/or neurite-like extensions. 
Further downstream, MAPK and Erk1/2 are activated when Nedd9 is over-expressed, 
but the increase in migration does not involve those pathways (Fashena et al., 2002), 
and might require JNK activation instead (Dolfi et al., 1998). Nedd9 induced 
expression results in transcriptional induction of MLCK, p160 ROCK, NIK Ser/Thr 
kinase, PAKα and several Rho which are functionally related to cell motility (Fashena 
et al., 2002). In the same study, Nedd9 was reported to cause upregulation of matrix 
metalloproteinases, ephrins ligands and receptors, and the NRG receptor ErbB2. 
However, Nedd9 pathway-target specificity for activation of those genes remains to be 
validated. Cell adhesion regulates conversion of Nedd9 isoforms from p105 into p115; 
a mobility shift which predominantly reflects serine/threonine phosphorylation state 
(Zheng and McKeown-Longo, 2002), and it is linked to integrin receptor activation and 
cytoskeletal organization (O’Neill and Golemis, 2001; Zheng and McKeown-Longo, 
2006), and favored Nedd9 proteasomal degradation (Zheng and McKeown-Longo, 
2006).  
Evidences supporting Nedd9 function in anoikis and apoptosis derive from in vitro 
over-expression experiments. Overexpression of Nedd9 28 KDa C-terminal peptide, 
similar to the naturally occurring after caspase cleavage, triggers apoptosis (Law et al., 
2000). Similar features were observed in weak tumorigenic cell lines after long-term 
Nedd9 full-length induced expression (Law et al., 2000). Nevertheless, apoptotic 
mechanisms were not induced when Nedd9 gain-of-function experiments were 
performed on highly metastatic and invasive cell lines (Kim et al., 2006; Natarajan et 
al., 2006). 
First conclusive experiments showing involvement of Nedd9 and some of its signaling 
partners in cell cycle progression were conducted by Pugacheva and Golemis (2005). 
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Cells over-expressing Nedd9 present multipolar spindles and supernumerary 
centrosomes, which overall cause defective cytokinesis (Pugacheva and Golemis, 2005) 
through mechanisms involving disruption of RhoA activation cycle (Dadke et al., 
2006). Consistently, when Nedd9 was knocked-down the centrosome separated 
prematurely and there was an increase in monopolar and asymmetric spindles 
(Pugacheva and Golemis, 2005), which resulted in abnormal high numbers of 
binucleate cells (Dadke et al., 2006). Other functions of Nedd9 related to cell 
cytoskeleton modifications in the formation of cilia were recently reported (Pugacheva 
et al., 2007).  
 
 
1.3.3 Control of Nedd9 expression levels. 
Several factors have being described that induce Nedd9 expression levels. TGF-β 
treatment was shown to promote Nedd9 transcriptional activity (Zheng and McKeown-
Longo, 2002). Nedd9 expression was induced in neuroblastoma cell lines by retinoic 
acid [Merrill et al., 2004a; b] and the 5’ region of the Nedd9 promoter has been 
reported to specifically bind a RAR-RXR heterodimer (Merrill et al., 2004a). While 
over-expression of progesterone receptor-A was found to increase Nedd9 levels (Richer 
et al., 2002), estrogen receptor-α over-expression and estrogen treatment 
downregulated Nedd9 (Monroe et al., 2003; Buterin et al., 2006). Nedd9 mRNA was 
induced after ischemia in rat cortex and hippocampus (Sasaki et al., 2005). Co-
occupancy of Nedd9 promoter by Sox2 and Nanog was recently reported (Boyer et al., 
2005), hypothetically suggesting its involvement in stem cells. Since Nedd9 expression 
is known to be induced in cells while cycling, with an expression peak at late G2/M, the 
increase in levels reported during cancer metastasis (Donninger et al., 2004; Kim et al., 
2006) may be associated with high proportion of actively cycling cells. Nedd9 levels 
are very low in quiescent cells (Law et al., 1998), and in cycling cells after mitosis due 
to proteasomal degradation (Law et al., 1998; Pugacheva and Golemis, 2005). 
Since Nedd9 can be cleaved by caspases, its shorter fragments may eventually function 
as dominant negatives for the full length active molecule (Law et al., 2000; O’Neill and 
Golemis, 2001). TGF-β through Smad3 can promote Nedd9 proteolysis and 
reciprocally Nedd9 can negatively regulate TGF-β signaling (Liu et al., 2000; Nourry 
et al., 2004; Inamoto et al., 2006). 
 
 
1.3.4 Nedd9 in development and nervous system repair. 
A Nedd9 knock-out was made by Seo et al. (2005). In contrast to p130Cas knockout, 
which dies at E11 (Honda et al., 1998), this mouse is viable and fertile as homozygote 
and does not present gross abnormalities in any tissue. This suggests functional 
redundancy with other Cas proteins.  
Nedd9 involvement in neural processes is suggested by high levels of Nedd9 present in 
early mouse brains (Kumar et al., 1992) and in the human neuroblastoma SH-SY5Y 
cells [Merrill et al., 2004a; b]. Nedd9 expression was found to be regulated by retinoic 
acid in neuroblastoma cells and hindbrain rhombomeres (Merrill et al., 2004a). By 
performing whole-mount embryo in situ screening in rats, Merrill and colleagues have 
also reported Nedd9 expression in the neural tube epithelium, DRG, the boundary cap 
as well as other non-neural tissues (Merrill et al., 2004a).  
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After global ischemia, Nedd9 is induced in cortical and hippocampal neurons and 
Nedd9 overexpression was shown to promote neurite elongation in PC12, suggesting 
Nedd9 involvement in axonal/dendrite outgrowth which may be relevant for neurvous 
system repair (Sasaki et al., 2005). It was recently shown in Drosophila that Cas 
proteins control axonal guidance during development, in an integrin dependent manner 
(Huang et al., 2007). 
In between E10.5 and E13.5 Nedd9 is expressed at higher levels in male gonads in 
mouse when compared to female ones (Nef et al., 2005), suggesting a role for Nedd9 in 
sexual differentiation. 
The C-terminal domain of Nedd9 was shown to interact with members of the Id family 
of transcription factors (Law et al., 1999), known to be expressed in the neural tube 
epithelium (Jen et al., 1997) and in the neural crest (Kee and Bronner-Fraser, 2001), 
and may contribute to maintaining a progenitor state (Garcia-Campmany and Marti, 
2007). 
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2 AIMS OF STUDY 
 
- Characterize changes in myelin proteins during Wallerian degeneration and 
establish hallmarks in order to monitor nerve degeneration process. 
- Analyze the effect of a single apotransferrin injection on nerve degeneration after 
mechanical or chemotoxic injuries. 
- Generate phenotypically and functionally mature Schwann cells from bNCSCs  
- Explore the potential of stem cell-derived Schwann cells in cell replacement 
strategies for nervous system repair. 
- Analyze Nedd9 expression pattern and function, with special focus on neural crest.   
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3 RESULTS AND DISCUSSION 
 
3.1 PAPER I: CHANGES IN MYELIN AFTER NERVE INJURY 
The degenerative processes triggered by nerve injury were first described by Augustus 
Waller in 1850 (reprinted in Stoll et al., 2002) and exhaustively analyzed by Santiago 
Ramón y Cajal (1928) in his main research field after gaining the Nobel Prize. In his 
publication, Ramón y Cajal described the roles of the different cells involved in 
Wallerian degeneration of transected fibers. As he mentioned, the initial events are 
accomplished by SCs alone and processes include: 1) increased in SC cytoplasmic 
volume; 2) interruption of the myelin sheath in the perinuclear region and 
fragmentation of the sheath into ovoids and ellipsoids; 3) the proliferation of SCs; and 
4) the progressive separation of lipoidal ovoids within SC tubes. Then, hematogenous 
phagocytic cells invade the whole nerve, cluster around the lipoidal masses and become 
intratubal, accelerating the removal of debris. 
Although studies nowadays are seldom done as detailed and meticulously as Ramón y 
Cajal’s, we have now much powerful tools to further uncover such mechanisms. It was 
the aim of this work to better understand how myelin degradation is achieved after 
peripheral nerve injury in newborn and adult rats. The main objectives of this work 
were: 1) to establish myelin protein immunohistochemistry as a procedure to determine 
hallmarks for monitoring nerve degeneration process, and 2) to temporally relate state 
of myelin clusters with myelin protein degradation. Since we were interested in 
analyzing in vivo myelin degenerative processes and to avoid confusing effects from 
newly synthesized myelin (known to occur after axonal re-growth through the distal 
stump), the ligation of the sciatic nerve was chosen as injury model. Animals were 
sacrificed at different time intervals in order to cover main steps in myelin processing 
and degradation. Myelin re-distribution within the nerve was monitored by use of 
specific myelin protein polyclonal antibodies on tissue sections. In parallel, analysis of 
myelin proteins integrity within the injured nerve was conducted by mean of SDS page 
electrophoresis. Protein loss was determined by measuring dry weight of isolated 
myelin fraction, normalized to humid nerve weight. 
In all cases, we have first observed increase accumulation of myelin proteins in clusters 
(the “coagulated particles” described by Waller) within SC tubes distally to the injury 
zone, together with increase in P0 and MBPs immunoreactivities within degenerating 
nerves mainly due to protein re-distribution. A higher exposure of myelin protein 
epitopes after partial degradation mediated by SCs may also partially explain our 
observations.  
In adult animals, maximum values of myelin protein immunostained areas were 
obtained at 7 days after injury, coinciding with peak of abundance of 
macrophages/monocytes within the nerve. This feature was found to precede the 
efficient degradation of myelin proteins. Overall, our results support the use of myelin 
protein immunohistochemistry as a tool for monitoring changes during nerve 
degeneration process. 
Proximally to the injury zone, alterations in P0 and MBPs staining intensities were 
observed at longer periods analyzed without resulting in appearance of myelin clusters 
within first 2 weeks after injury. These results are consistent with a cellular re-
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distribution and/or modification of the myelin protein epitopes allowing higher binding 
of antibodies within cells morphologically resembling SCs after injury. A decrease in 
dry weight values of isolated purified myelin fractions was observed in areas 
proximally to the injury zone, likely due to partial loss of myelin proteins influenced by 
exacerbated macrophage activity. Alternatively, an increase in humid weight of nerves 
at regions proximal to the ligature due to plasma exudation may explain observed 
changes. 
Our results suggest that myelin protein antibodies we used have very different affinities 
to their specific epitopes since much higher immunoreactive area values were obtained 
for MBPs in nerve sections when compared to P0. Alternatively, epitope modifications 
produced within SCs may differ in between proteins analyzed. Finally, protein 
degradation rates mediated by macrophages may differ from cytosolic proteins like 
MBPs to transmembrane proteins like P0 (Proost et al., 1993), as suggested by results 
from both electrophoresis and image analyses on nerves distally to the injury zone. 
In this study, we also report an increase in the 14 KDa MBP protein isoform. Our 
preliminary studies of amino acid sequences from peptides at this band suggest 
presence of fragments with high homology to alpha and beta-globins. Further work 
conducted in my previous lab showed that these proteins are in fact synthesized in 
injured nerves by macrophages and hematopoietic progenitors (Setton-Avruj et al., 
2007), in opposition to previous reports suggesting repression of alpha-globins at 3 
days after sciatic nerve crush (De Leon et al., 1991).  
Nerve degeneration was found to be accelerated in newborn rats when compared to 
adult animals, likely due to higher metabolic rates in the former group, but remained 
essentially similar in the occurrence of myelin proteins accumulation before their final 
degradation. 
 
 
3.2 PAPER II: TRANSFERRIN PREVENTS NERVE DEGENERATION IN A 
CYTOTOXIC INJURY MODEL 
In paper I, we have characterized nerve degeneration process by monitoring changes in 
distribution of myelin protein immunoreactivities. We were then interested in analyzing 
the effect of transferrin on nerve degeneration/regeneration and for this purpose we 
chose two alternative injury models allowing further regeneration: 1) the nerve crush, a 
traumatic model which involves necrosis, ischemia and blockage of axonal transport, 
and 2) intraneural colchicine injection, transiently affecting axonal transport.   
The development of this project was in fact one of the main purposes for a large 
collaboration launched (in my previous lab in Austral University, under the supervision 
of Marcelo J. Villar) with a lab partner, led by Prof. Juana M. Pasquini and Dr. Eduardo 
F. Soto, at the University of Buenos Aires/IQUIFIB-CONICET (Argentina). Our 
collaborators have a long history of research focused on the effects mediated by 
transferrin in oligodendrocyte maturation and CNS myelination (Cabrera et al., 2000; 
Marta et al., 2002; 2003; Garcia et al., 2004; Paez et al., 2005; 2006; Adamo et al., 
2006) and have reported that this protein prevents Schwann cells de-differentiation in 
vitro (Salis et al., 2002).  
We have first characterized nerve degeneration process by analyzing myelin and axonal 
protein immunoreactivities at different time periods in between 1 and 60 days. For 
myelin protein characterization we have chosen MBPs as epitope after having seen its 
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great variations through degenerative processes in paper I. In case of axonal markers, 
PGP9.5 and beta-III-tubulin (also known as Tuj1) were used since both label virtually 
all neurons in the sciatic nerve. Application of the two injury models used in this paper 
resulted in Wallerian degeneration likely resembling descriptions of paper I with a 
delayed in myelin protein clustering onset in colchicine model (Singer and Steinberg, 
1972). The degree and intensity of the degenerative processes triggered by colchicine 
were dose-dependent but even at highest colchicine concentrations used, scores of 
MBP-immunostained area were 50% lower than in crushed or ligation models. First 
signs of neural alterations after colchicine application, distally to the injection site, were 
observed on axonal proteins consistent with that SC de-differentiation follows loss of 
healthy axonal contact (Liu et al. 1995a). For 10nM colchicine condition, the peak of 
MBP clustering appearance was observed at 14 days after injury, 7 days later than in 
traumatic injury models. By 1 month after injury, in both injury models, nerve is 
already normalized when looking at markers analyzed: axons have regenerated and 
myelin was re-synthesized. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1: Changes in myelin and axonal proteins during Wallerian degeneration. Upper left: 
Confocal images showing normal distribution of MBPs+ myelin ensheathing PGP9.5+ axons. Upper 
right and lower left: at 7 days after injury, MBP+ ovoids included in Schwann cell tubes contains 
fragments of remaining axonal debris. Lower right: at 14 days, myelin degradation products are very 
often found included in macrophages which efficiently remove and digest them.     
 
Immunofluorescence studies on transected fibers have revealed presence of both 
PGP9.5 and MBPs stainings within same ovoid myelin clusters inside SC tubes at 3 
and 7 days after injury (unpublished data; Fig.1). At 14 days after injury, these clusters 
acquire a rounded morphology and are mostly included in ED1+ macrophages (Fig.1). 
These features suggest that SCs play a role in isolating myelin and axon-derived debris 
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in same lipoidal structures, known to be covered by vimentin layers synthesized by 
same SCs (Liu et al., 1995a). 
Intraneural injection of apotransferrin (0.5 µg/ml to 0.5 mg/ml) simultaneously to 
colchicine (5mM) prevented Wallerian degeneration, since no features of axonal 
disruption or clustering of myelin protein signals were observed at 7 days after 
application. Given that transferrin was unable to prevent crush-induce nerve 
degeneration we speculate that transferrin works in colchicine injured nerves by 
stabilizing axonal cytoskeleton but is not able to counteract events triggered by 
hypoxia/necrosis caused by mechanical injuries likely mediated by mechanisms 
involving early calcium entry into axons and subsequent proteolytic enzyme activation 
(Banik, 1992; Martinez and Canavarro, 2000; Wang et al., 2000). Molecular 
mechanisms mediated by transferrin in prevention of nerve degeneration were not 
addressed experimentally in our work. Available literature at present mostly highlights 
effects of transferrin on myelinating glia, which are known to express the transferrin 
receptor (Cho et al., 1997). This would suggest a role of Schwann cell cytoskeleton 
stability in prevention of axonal degeneration likely involving transcriptional events 
(Marta et al., 2002; Paez et al., 2006). Alternatively, transferrin may exert direct effects 
on axonal cytoskeleton (Kiffmeier et al., 1991). Increase in transferrin levels have been 
reported within motoneurons in models of progressive motor neuronopathy (Moos, 
1995). However, transferrin receptors are known to be absent from axons proximally to 
the injury zone (Raivich et al., 1991), and are only found in the neuronal soma while 
motoneurons regenerate (Graeber et al., 1989).        
It was recently demonstrated that Schwann cells synthesize transferrin during their 
maturation and after nerve injury (Salis et al., 2007). In the latter condition, it is 
interesting that SCs express transferrin mRNA in between 3 and 7 days post-injury, too 
late for being involved in prevention of nerve degeneration but eventually required for 
myelin protein clustering and partial phagocytosis. 
 
   
3.3 PAPER III: EFFICIENT GENERATION OF SCHWANN CELLS FROM 
NEURAL CREST STEM CELLS 
Jens Hjerling-Leffler training and expertise in isolating and obtaining highly pure 
cultures of boundary cap stem cells from E11.5 mouse, under the supervision of Patrik 
Ernfors, led our lab into the field of neural crest stem cells. In their work, they have 
characterized bNCSCs and differentiated them into peripheral sensory neurons which 
were shown to present similar cytological and physiological properties than those of 
adult DRG (Hjerling-Leffler et al., 2005). 
Schwann cell differentiation from NCSCs was first published by David J. Anderson’s 
group (Stemple and Anderson, 1992; Shah et al., 1994). However, they have not 
expanded these NCCs into formation of neurospheres. Afterwards, Amoh et al. (2005) 
have placed clones of skin-derived NCSCs into the injured area of the rat sciatic nerve 
and claimed to have obtained Schwann cells which were responsible for behavioral 
improvements. However, they failed to sufficiently characterize those NCSC-derived 
GFAP+ cells which present features not corresponding with mature SCs.  
We have started by analyzing the fate of bNCSCs when grafted into intact sciatic 
nerves. In order to identify them in host tissue we have produced NC stem cells from 
boundary cap of Rosa26 mice ubiquitously expressing the bacterial beta-galactosidase 
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(lacZ; Zambrowicz et al., 1997). As hosts we used rats, since their larger nerves are 
easier to handle. Additionally, mouse nuclei differentially present a punctuated pattern 
of staining after Hoerscht labeling helping in the identification of grafted cells (Dupin 
et al., 1990; Sextier-Sainte-Claire Deville et al., 1994). As previously shown for 
NCSCs (Amoh et al., 2005), bNCSCs generated GFAP+ glia after being grafted into the 
rat sciatic nerve. However, no S100+ Schwann cells were found when tissue was 
analyzed which suggested the need of additional factors, not provided by the intact 
nerve, to generate them. Consistently, in defined culture medium, bNCSCs were found 
to become mostly GFAP+ glia and at lower frequency Tuj1+ neurons or smooth muscle 
cells. Very few cells expressed S100+ at 5 days under these in vitro conditions.  
We then looked into protocols for priming stem/progenitor cells and designed one 
based on previously published reports (Wu et al., 2002), but removing bFGF since it is 
known to direct neuronal fate (Whittemore et al., 1999). In search for factors promoting 
a Schwann cell phenotype from cell progenitors, we found abundant literature 
suggesting that neuregulins may be one of such factors (Shah et al., 1994; Meyer and 
Birchmeier, 1995; Riethmacher et al., 1997; Morris et al., 1999; Woldeyesus et al., 
1999). When the EGF domain of heregulin (Neuregulin-1 type I; shared by other 
neuregulins, Garratt et al., 2000) was added to culture medium recipe, bNCSCs 
differentiated into S100+/GFAP- late Schwann cell precursors already at 5.5 days in 
vitro. Those cells presented two or three elongated processes and oval blunt ended 
nuclei and formed pavement-like arrays, properties already described for Schwann cell 
precursors (Jessen and Mirsky, 2002). At 5.5 days after plating few cells were found to 
in addition express GFAP, known to identify the change from a Schwann cell precursor 
to an immature phenotype (Jessen et al., 1990). With time, GFAP expression was 
induced in all Sox10+ cells in vitro, as well as Krox20 in a subpopulation which 
consists in the myelinating Schwann cell phenotype (Topilko et al., 1994; Parkinson et 
al., 2004). At 30 days in vitro, Schwann cells down-regulated Sox2 suggesting that they 
have adopted a mature phenotype, since both Schwann and satellite glia cells (the two 
described types of peripheral glia) in adult DRG and/or nerves do not express this 
marker. As expected, at 3 days after crushing of the rat sciatic nerve Sox2 was up-
regulated in Schwann cells (our unpublished results), known to de-differentiate after 
injury up to at least an immature Schwann cell stage (Jessen and Mirsky, 2005). We 
have further characterized in vivo and in vitro the changes in protein expression pattern 
of Schwann and satellite glia cell lineages (see Figure 2). Most of them were at least 
partially shared by both glial cell type lineages.  
Interestingly, at E10.5-E11.5 Sox2 was found to be expressed at low levels in NCCs at 
the boundary cap and around the DRG (in vivo and in vitro) but when cells became 
glial progenitors (in vivo, from E11.5) or Schwann cell precursors (in vivo -from E12.5- 
and in vitro -from 5.5 days in culture-) they highly up-regulated Sox2 expression (our 
unpublished results). Therefore, increase in Sox2 expression levels seems to mark 
restriction of neural crest to the glial lineage and suggests that Sox2 might be involved 
in glial restriction in the PNS. 
From in vivo analysis of mouse embryonic GFAP expression pattern, our results 
suggest that some Schwann cells are already born at E12.5 in mouse. Interestingly, at 
this stage GFAP was found to be expressed within nerves at distal regions suggesting 
that Schwann cell differentiation might proceed in a centripetal way. 
We have also described for first time expression of Sox10 in adult mouse peripheral 
glia. S100 expression in vivo in some but not all satellite glia cells suggests the 
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existence of different subpopulations of this cell type. Finally, co-expression of Sox10 
and Krox20 together with morphological criteria and cell localization helped us to 
describe presence of Schwann cells within the DRG. 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2: Characterization of in vivo and in vitro (from boundary cap neural crest stem cells) Schwann 
cell lineage differentiation.    
 
In order to confirm the nature of bNCSC derived SCs and to address their capacity to 
function as such, we tested their ability to myelinate axons. For that purpose we 
established a co-culture system. Dissociated bNCSCs were differentiated into Schwann 
cells for 9 days and C57Bl/6 DRG explants were then added to those cultures. After 31 
days of incubation, cultures were fixed and immunostained for Tuj1 and MBP. Xgal+ 
stem cell-derived SCs were found to ensheath C57Bl/6 axons which nicely responded 
to signals derived from our differentiated stem cells by defasciculating when entering 
the bNCSC pool. Furthermore, bNCSC-derived SCs expressed MBP indicative of their 
capacity to myelinate. This was confirmed in vivo by grafting silicone tubes containing 
bNCSC-derived SCs (pre-differentiated in vitro for 25 days, suspended in Matrigel®) 
into axotomized rat sciatic nerves: Xgal+ SCs were found to ensheath rat axons and 
express MBP at 90 days after injury. As expected, pre-differentiated SCs were not able 
to migrate extensively and therefore did not reach proximal or distal stumps of nerves. 
After we published these studies, some reports appeared on differentiation of skin-
derived neural crest stem cells into Schwann cells also showing that those cells can 
myelinate (McKenzie et al., 2006; Biernaskie et al., 2007b). Interestingly, SCs derived 
from skin NC stem cells were shown to significantly survive after grafting into the 
injured spinal cord and to produce several beneficial effects including tissue sparing, 
suppression of reactive gliosis, and promotion of axonal outgrowth and of endogenous 
SC recruitment within the injury zone. Nevertheless, improvements in locomotor 
behavior after spinal cord injury were mild when compared to control and not 
significant when involving superior central processes (Biernaskie et al., 2007b). In vitro 
In vivo 
In vitro 
 5 hours        5 days      30 days 
Sox10 + Krox20
Sox10 + Sox2 
Sox10 
Fibronectin
Fibronectin + S100 + GFAP 
S100
E10-10.5             E12.5                 P14 / adulthood
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protocols used in Freda Miller’s group were very similar to the ones we have applied 
(Biernaskie et al., 2007a).    
In an attempt to address regenerative capacity of bNCSCs, we have again placed cells 
suspended in Matrigel within silicone tubes and after 2 days of SC differentiation 
treatment in NRGs we grafted them into axotomized rat sciatic nerves. Controls 
consisted in tubes lacking from stem cells incubated with (NRG) or without (N2) 
addition of NRGs. Animals were electrophysiologically tested at 90 days after injury 
and then perfused and tissue was analyzed. Interestingly, bNCSCs did not differentiate 
into Schwann cells and became instead S100-/GFAP+/Sox2+ glia, suggesting the 
requirement of long-term treatment with neuregulins for significantly generating 
Schwann cells and reducing undesired phenotypes. In bNCSCs condition, slight but not 
significant improvements in electrophysiological responses were observed considering 
foot muscle innervation, when compared to N2 control condition (see Figure 3). 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3: Measurement of parameters suggesting NRG mediated enhancement of axonal 
regeneration and non-beneficial effect of grafting un-differentiated bNCSCs (A,B,D) Graphs 
showing electromyogram responses in gastrocnemius (A,B) or foot (D,E) muscles: detection or non-
detection of spontaneous (A,D) or voluntary (B,E) responses in each of animals tested were scored 
as 1 or 0, respectively. (A) Note that while in both N2 and NRG+bNCSCs conditions all animals 
presented spontaneous activities at 100 days after injury, in 40% of NRG treated animals muscle 
innervation was fully achieved and therefore no spontaneous activities could be detected. (E) Note 
that all NRG treated animals showed voluntary peaks of activity in EMG measurements while this 
was found in 60% of NRG+bNCSCs treated animals and in only 20% of N2 treated animals. (C) 
Grafting of bNCSCs non-SC pre-differentiated resulted in a minor gain in gastrocnemius weight 
(measured as percentage of the contralateral gastronemius weight) when compared to NRGs treated 
group. (F) Current velocity (as percentage of the contralateral) is increased in NRG treated animals 
when compared to N2 treated ones. * p<0.05. ** p <0.01 
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Interestingly, NRG treatment resulted in: 1) complete innervation of the gastrocnemius 
muscle in 40% of animals; 2) significant recovery in the gastrocnemius size; 3) 
appearance of voluntary activity in electromyogram of foot muscles in all animals 
tested, and 4) significant improvements in current velocity in between sciatic notch and 
foot muscles (Figure 3). The observed effects likely involves enhance stimulation of SC 
proliferation and migration (Son and Thompson, 1995; Mahanthappa et al., 1996; 
Trachtenberg and Thompson, 1996).  
 
 
3.4 PAPER V: STEM CELL-DERIVED SCHWANN CELLS PROMOTE 
RECOVERY AFTER SPINAL CORD CONTUSION INJURY 
Our success in obtaining highly pure cultures of Schwann cells from neural crest stem 
cells prompted us to study the repair capacity of these cells. In order to pursue this aim 
we have collaborated with Lars Olson group at the Department of Neuroscience 
(Karolinska Institute) who have developed tests for performing controlled injuries of 
the rat spinal cord and tested the effect of different cell types in CNS repair (Hofstetter 
et al., 2002; 2005). Cells were grafted one week after moderate weight-drop spinal cord 
injury and BBB locomotor tests (Scheff et al., 2002) were performed weekly in order to 
analyze the effect of transplantation. Already one week after grafting animals showed 
improved locomotor function when compared to control group (on BBB subscore 
measurements, in which parameters requiring a certain level of coordination are 
evaluated). Our time course analysis of early stages after cell transplantation evidenced 
existence of sufficient axonal re-growth and glial invasion at the injury core to suggest 
a possible involvement of regeneration in behavioral outcome. Cell transplanted 
animals reached significantly higher BBB locomotor scores and sub-scores. Grafted 
animals showed significant improvements in grid-walk test at 3 months after injury, 
suggesting recovery of superior levels of integration. Significant improvements in 
locomotor function were also achieved when a stronger weight drop force was applied.  
In order to easily identify grafted cells, Schwann cells were derived from Rosa26 
bNCSCs. When tissue was analyzed at 3 months after injury, no lacZ+ grafted cells 
were observed in sectioned spinal cord in most of animals. In order to draw a time 
curve of cell death after grafting, groups of 3-4 animals were perfused at 2, 7 and 14 
days after transplantation.  Surprisingly, no mouse derived Schwann cells were found in 
any of the experimental rats, not even at 2 days after grafting. Schwann cell death has 
also been previously reported when mature SCs were grafted into injured spinal cord 
(Hill et al., 2006) and it is likely due to absence of axons within the injury zone 
required for Schwann cells in order to survive. We have then asked ourselves if cells 
need to be transplanted alive in order to obtain the significant recovery. In order to 
address this question, cells were freeze-thaw killed before transplantation. Interestingly, 
the behavioral improvements after grafting of dead cells were not as robust as when 
cells were placed alive. From previous results, we concluded that endogenous 
mechanisms mediate the beneficial effects of grafting stem-cell derived Schwann cells. 
In transplanted animals, values of total spinal cord area at the injury zone as well as 
other size parameters measured in the dorsal funiculus area both rostrally and caudally 
to the injury zone were increased when compared to control condition. This is likely 
due to reduced atrophy in grafted animals as a result of differential axonal re-growth 
and endogenous glia recruitment through the injury zone. Consistently, cell 
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transplantation resulted in increase in axonal innervation and in density of Sox10+ glia 
not only at the injury zone but also rostrally and caudally to it at three months after 
injury when compared to controls. These results could also be due in part to 
neuroprotective effects and in fact at 3 months after injury decreased 
immunoreactivities to OX42 (a marker for activated microglia and macrophages) were 
observed in the dorsal funiculus of transplanted animals when compared to controls, 
proximally to the injury zone. 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 
Fig. 4: Presence of p75+/Sox10+ Schwann cell-like cells within the injury zone at 100 days after 
spinal cord moderate contusion.     
 
The identity of recruited endogenous glia after injury was studied. Interestingly, at 
areas proximally to and within the injury zone the majority of cells were found to 
consist in p75+/S100+/P0+/Sox10+ Schwann cell-like cells (SCLCs) which at least in 
part may derive from progenitors within the CNS (Figure 4). However, distally to the 
injury zone the recruited cells consisted in p75-/S100-/P0-/Sox10+ oligodendrocytes, 
suggesting differential mechanisms of glial cell recruitment at different levels of the 
injured spinal cord. Number of p75+ cells in areas proximal to and within the injury 
zone was significantly higher in cell grafted animals when compared to control group. 
Nevertheless since a similar pattern of endogenous glia recruitment was found in both 
experimental and control conditions when compared to naïve spinal cord, our results 
suggest that stem cell-derived Schwann cell transplantation at 7 days after injury 
enhance naturally occurring endogenous reparative mechanisms after injury.  
We have then analyzed the dynamic of changes in cell types within the injury zone and 
proximally and distally to it in grafted animals (Figure 5). For this characterization we 
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used the combination of four different markers: Sox2 (expressed by the ependymal 
layer of the spinal cord central canal as well as by mature astrocytes and 
oligodendrocyte progenitors, and after injury also in different progenitor and immature 
glial cells), Sox10 (in oligodendrocytes and SCLCs), p75 (in SCLCs) and Rip (glia 
specified to myelinate, strongly expressed in oligodendrocytes). At two days after 
injury, very few cells were found to be labeled by these markers within the injury zone, 
suggesting the loss of most CNS cells at the affected area. Interestingly, many 
Sox2+/Sox10+ oligodendrocyte or SCLC progenitors were found at areas rostrally and 
caudally to the injury zone and they were more concentrated close to the spinal cord 
central canal than in its peripheral areas. It is worth noting that few Sox2-/Sox10+/Rip-
/p75+ apparently mature SCLCs were found in proximal areas of the injury zone. At 7 
days after grafting, glia within the injury zone consisted mainly in Sox2- SCLCs which 
have increased in numbers and reached levels of the distal injury zone. Finally, at 14 
days after transplantation SCLC population was even more represented at the injury 
zone but now Sox2+/Sox10- astrocytes, derived from the ependymal epithelium, 
reached central areas of the injury and intermingled with SCLCs. Very few 
Sox2+/Sox10+ progenitors were found within the injury zone at all time points analyzed. 
In conclusion, it seems likely that already differentiated SCLCs invade the injury zone 
mostly from proximal unaffected areas and this population is expanded over time even 
though it does not express Sox2. Since SCLC population was found to invade in 
correlation with axonal re-growth through the injury zone, it is likely that axonally 
derived signals are required for glial proliferation and survival. And our results also 
support a role for the expanding endogenous glia population in helping axons to grow 
through the injury core. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Changes in glial cell populations and axonal re-growth in the injured area after spinal 
cord contusion. Schematics showing dynamic changes within the injured area of the spinal cord at 
9 (B), 14 (C) and 21 days (D) after moderate contusion, when compared to un-affected areas (A). 
Note that after injury most of cells die within the injury zone and this area is filled with microglia 
and activated macrophages. (A) In healthy spinal cord, ependymal cells lying in central canal wall 
express Sox2 (red) and constitute a pseudo-stratified epithelium. Glial cells express either Sox2 
A B
C D
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(astroglia) or Sox10 (blue; oligodendrocytes). (B) Two days after cell transplantation, the ependyma 
becomes stratified and disorganized and some cells differentiate into Sox10+ myelinating glia 
progenitors (co-expressing Sox2; yellow); p75+/Sox10+/Rip-/Sox2- Schwann cell-like cells appeared 
in proximal areas of the injury zone (cells with oval blue nuclei) and some reach central levels of the 
injury zone; axons (green) grow in parallel to Schwann cells; (to the right) abundant oligodendrocyte 
progenitors appear in spinal cord parenchyma at levels rostral and caudal to the injury zone and the 
density of these cells decreases from central to peripheral aspects of the spinal cord. (C,D) At 7 days 
and 14 days after grafting, density of Schwann cell-like cells and axons within the injury zone 
increase with time.   
 
 
In our studies, we provide for first time evidences that cells within the ependymal 
epithelium are able to generate in vivo oligodendrocyte/SCLCs after injury (Figure 5). 
At 9 days after injury, several Sox2+/Sox10+ cells were found within the disorganized 
spinal cord central canal epithelium which has become discontinued and opened to the 
injury zone at this stage. In order to analyze the participation of ependymal cells in 
generation of recruited endogenous glia after injury, lineage tracing studies using 
specific inducible mouse strains would be required. 
At 3 months after injury, endogenous SCLCs were found to express both P0 (a myelin 
protein specific for peripheral glia) and Rip and to myelinate axons. Nevertheless, most 
of these cells still expressed p75 which is normally down-regulated in mature Schwann 
cells of the myelinating phenotype (Figure 4). The coexistence of immature features in 
SCLCs may partially explain why the degree of myelination and functional recovery 
after injury are minor when compared to normal conditions before injury. Presence of 
high numbers of macrophages/glia at the injury zone and factors they produce may 
cause such characteristics in endogenous SCLCs and block their complete maturation.  
 
 
3.5 PAPER IV: NEDD9 MAKES MULTIPOTENT NEURAL CREST CELLS 
MOVING 
Frédéric Marmigère’s findings on homeobox-sequence containing proteins highly 
enriched in neural tube and DRG at intermediate stages of mouse development by using 
a degenerate PCR approach has opened interesting lines of research in our lab 
(Marmigere et al., 2006). One of the mRNA that has been fished was Nedd9. Fred has 
successfully cloned a probe of 498 bp corresponding to a fragment in the C-terminal 
domain of Nedd9, including part of a divergent helix-loop-helix motif, which has 
shown no significant homology with any other paralog member in the Cas protein 
family. Nedd9 expression pattern was characterized by in situ hybridization (ISH) on 
sections. Interestingly, Nedd9 expression was observed in multipotent migrating and 
postmigratory NCCs at E9.5-E10.5 in mouse. Apart from that, its pattern of expression 
in the nervous system highly resembled the ngn2 one. These two findings prompted 
further investigations. 
To address Nedd9 function in NCCs, the first step we have taken was to obtain Nedd9 
full length. Our strategy was to overexpress it in chick by mean of in ovo 
electroporation. Since mouse construct has being published by Erica A. Golemis and 
colleagues, we contacted her to ask for it and she very generously sent it to us. The 
construct, originally in pcDNA3, was sub-cloned into a pCA vector, to drive Nedd9 
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expression under the chick actin promoter. First results suggested a role of Nedd9 in 
NCC motility since a significant increase in number of Nedd9 targeted cells reaching 
farther distances in the trunk was seen. In vitro experiments, both in mouse bNCSC 
neurospheres (studies not included in the manuscript) and bNCSC-derived SCs were 
consistent with that Nedd9 is sufficient to increase migration in NCCs or derivatives. 
Interestingly, long-term sustained expression of Nedd9 resulted in loss of neural crest 
cells from all NCC target places, likely due to apoptosis. Since, it seems that normal 
induction scheme of Nedd9 is sufficient to drive NCC delamination and migration 
efficiently and that much of phenotype could be due to artificial sustained Nedd9 
expression, we concluded that to study its role in a more physiological context loss-of-
function models would be more relevant.  
We have then designed siRNA naked constructs and repeated in ovo electroporation 
phenotype studies. To our surprise, a very significant depletion from targeted NCCs at 
hindlimb levels of the trunk resulted from our first pilot experiment, already at 1.5 days 
after electroporation. The fact that delamination phenotype was specific for hindlimb 
levels of the trunk could be due to the fact that an efficient depletion from Nedd9 
functional threshold levels may only be reached at this region. Alternatively, it could be 
explained by requirement of Nedd9 and β1 integrin signaling for NCC delamination at 
this specific axial level (Bronner-Fraser, 1986; Tucker, 2004). Apart from that, cells 
which were able to detach migrated much poorly when compared to controls. These 
phenotypes were shown to be siRNA dose dependent. We have then made a chick 
probe for Nedd9 ISH, which show expression of Nedd9 mRNA in NCCs, and 
confirmed that Nedd9 mRNA is knocked down by our siRNA. Reduction of Nedd9 
protein expression levels in NCCs was also observed after Nedd9 siRNA 
electroporation. Another Nedd9 siRNA construct was designed to confirm Nedd9 
knock-down specificity and, as expected, its application resulted in a similar phenotype 
to the previous one. Interestingly, NCC delamination and migration deficiency was not 
transient since it was still present and aggravated at 3 days after electroporation. The in 
vivo functional studies were confirmed in vitro by explanting neural tubes and 
analyzing migratory properties in targeted NCCs. 
We then turned into investigating whether Nedd9 function in multipotent NCCs 
motility was dependent on integrin ligands and to address this question NCCs which 
migrated out from explanted neural tubes were collected, dissociated and re-plated on 
laminin (ligand of integrins) or poly-D-lysine or heat-denatured laminin (not ligands of 
integrins). NCCs were only able to efficiently spread in laminin, and Nedd9 siRNA 
caused a significant reduction in cell spreading area when compared to control. While 
the majority of scrambled siRNA targeted cells presented a migratory phenotype, 
Nedd9 depleted NCCs were mostly stationary (Strachan and Condic, 2003).  
Finally, since Nedd9 was reported to function in cell lines as scaffolding protein within 
integrin signalling pathways and it was suggested to regulate focal adhesion and actin 
cytoskeleton dynamics, properties involved in cell motility, we have analyzed 
expression of paxillin (a marker of focal complexes) and phalloidin (a marker of actin 
filaments) in control and Nedd9 siRNA targeted cells. Nedd9 loss-of-function resulted 
in decreased levels of focal complexes and actin filaments, a feature that was 
remarkable in central areas of the cell which almost lack from both sub-cellular 
components. Stress fibers which are normally found in a fraction of NCCs were rarely 
seen in Nedd9 deficient cells. The latter phenotype was previously reported in context 
of p130Cas cell deficiency (Honda et al., 1998). 
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3.5.1 Nedd9, a marker for multipotency in neural crest cells. 
It was reported that the majority of migrating NCCs are likely multipotent (Le Douarin 
and Kalcheim, 1999; Dupin et al., 2007). In our expression pattern analysis we have 
observed that most of NCCs co-express Nedd9 and high levels of Sox10, known to 
identify multipotency in migrating NCCs (Kim et al., 2003). Interestingly, while Sox10 
expression is kept in NCCs fated to a glial lineage, Nedd9 is not longer expressed in 
neural crest lineage at E12.5, developmental stage in which most if not all NCCs are in 
vivo lineage committed (our published results; Montelius et al., 2007). This likely 
suggests that Nedd9 is a marker able to discriminate multipotent NCCs from early 
neuronal or glial progenitors. Interestingly, the fact that β1 integrin was reported to be a 
marker for stem cells (Hall et al., 2006) and that Nedd9 promoter was found occupied 
by Sox2 and Nanog in embryonic stem cells (Boyer et al., 2005) suggests a role for 
Nedd9 in multipotent progenitor cells. 
Regarding NCC potential and heterogeneity, in this work we have described different 
neurogenin 2 (ngn2) mRNA expression levels in the migratory neural crest: while low 
or no expression of ngn2 was found in different subpopulations of Sox10+ NCCs, 
strong ngn2 expression was mutually exclusive with Sox10 expression. Zirlinger et al. 
(2002) have reported that expression of ngn2 marks a subpopulation of NCCs biased to 
a sensory but not a neuronal fate. Others have reported that ngns promote neuronal 
differentiation (Ma et al., 1996; Perez et al., 1999). Our finding of different ngn2 levels 
of expression in migrating NCCs makes possible therefore to interpret the apparently 
contradictory results reported by Zirlinger et al. (2002), using lineage tracing, and Ma 
et al. (1996) or Perez et al. (1999), using gain of function models. Higher levels of ngns 
expression might promote neuronal specification in progenitor cells. The ngn2 strongly 
expressing NCCs are likely sensory neuron progenitors reported to have limited 
proliferative and migratory capacity before they reach their homing place and 
contribute to the first wave of DRG neurogenesis (Ma et al., 1999). Since Nedd9 is 
down-regulated in migratory cells already specified to become neurons, this may partly 
explain why cells expressing high levels of ngn2 stop migrating, triggering DRG 
condensation. 
 
 
3.5.2 Nedd9 expression is induced by retinoic acid in neural crest cells. 
Our quantification analyses in vivo showing changes in Nedd9 expression levels in 
migrating NCCs suggested that a signal derived from the dermamyotome induces this 
expression. A peak in intensity of Nedd9 immunoreactivity was seen in NCCs upon 
dermamyotome dorsal lip proximity and decreased in cells which have passed this 
landmark downward (Figure 6). 
In order to elucidate which molecules induce Nedd9 expression in NCCs, a number of 
inducible factor candidates and/or of their antagonists/inhibitors were applied for 6 
hours on neural tube explant cultures (all-trans retinoic acid, citral, BMP4, Noggin, 
FGF8, Shh, Wnt3a, Wnt3a plus BMP4, Wnt5a or none –control-). From all factors 
tested, retinoic acid is likely the factor inducing Nedd9 expression. Several 
experimental outcomes support this statement: 1) the highest Nedd9 expression levels 
were obtained in our in vitro model system when explants were cultured in presence of 
high retinoic acid; 2) upon citral treatment (an inhibitor of retinoic acid biosynthesis; 
Kikonyogo et al., 1999; Song et al., 2004), Nedd9 was down-regulated in migrated 
cells with values significantly lower than in control condition; and 3) retinoic acid 
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injection in pregnant mothers up-regulated Nedd9 expression in trunk neural crest of 
E9.5 mouse embryos after 6 hours of treatment. A minor increase in Nedd9 expression 
was seen for FGF8, Wnt3a and Shh treatments; however, whether or not this result is a 
consequence of direct or indirect Nedd9 expression regulation remains to be address. 
Our results suggesting retinoic acid induction of Nedd9 are consistent with dynamic 
changes in Nedd9 expression patterns in NCCs. It is known that the expression of 
Raldh2, the main enzyme synthesizing retinoic acid in the trunk, increases in a 
posterior-to-anterior fashion in somites and peaks at the level of somite dissociation 
into dermamyotome and sclerotome (Haselbeck et al., 1999). And consistently, and 
since Nedd9 is involved in NCC motility, first NCCs migrating down through the 
rostral half of the somite do so at this very same trunk level (Erickson and Perris, 
1993). 
Based on our results and on available literature already discussed, we propose that a 
retinoic acid regulation of Nedd9 expression gives multipotent NCCs competence to 
respond to extracellular signals and to initiate migration through the sclerotome in an 
integrin dependent manner (Figure 6). Our data suggests that Nedd9 is implicated in 
regulation of focal complexes and actin filaments in NCCs, required for cell adhesion 
and spreading and for the development of traction forces which altogether drive 
motility. Our results also suggest Nedd9 involvement in neural crest delamination from 
the neural tube dorsal roof likely through similar mechanisms. 
 
 
 
 
Fig. 6: Nedd9 expression pattern and regulation in neural crest cells. (A) Nedd9 (red) is 
expressed at high levels in the neural tube roof plate during neural crest delamination. (B) 
Expression levels of RALDH2 in somites are increased from posterior to anterior regions of the 
trunk and peaks when they dissociate into dermamyotome (blue) and sclerotome (Haselbeck et al., 
1999), and at this axial level neural crest start migrating through the sclerotome. Nedd9 expression 
in migrating neural crest is induced when they contact the sclerotome and downregulated thereafter. 
(C) Nedd9 is expressed in postmigratory neural crest at the borders of the DRG and boundary cap an 
it is downregulated when cells become specified to neuronal lineage. Our functional results indicate 
that Nedd9 is required for multipotent neural crest cell migration. RP: roof plate. NT: neural tube .   
 
 
3.6 PAPER VI: NEDD9 IS EXPRESSED IN MULTIPOTENT/OLIGOPOTENT 
PROGENITORS OF DIVERSE TISSUES 
As mentioned before, one of the features that called our attention from Nedd9 in situ 
hybridization expression patterns was its correlation with ngn2 expression at different 
levels of the neural tube, from the mesencephalic ventral midbrain up to caudal regions 
of the trunk. In parallel to characterizing Nedd9 expression in NCCs we decided to map 
NT 
RP 
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NT 
RP 
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it all through the mouse embryo at intermediate stages of development in which Nedd9 
is expressed. Both in situ hybridization and immunohistochemistry were then 
performed on sections from E9 to E12.5 embryos. 
Nedd9 mRNA expression has already been reported in mammals but this 
characterization was done at whole rat embryo level (Merrill et al., 2004a). Therefore 
its characterization at the cellular level during mammalian development was unknown. 
We have first studied Nedd9 mRNA expression on trunk sections at E9.5-E10.5 mouse 
equivalent stages. Nedd9 was expressed at high levels in Sox2+ cells of the neural tube 
ventricular zone at two dorso-ventral domains corresponding mostly to Ngn2 mRNA 
expression domains (our results; Scardigli et al., 2001; Simmons et al., 2001) but 
extended ventrally reaching the floor plate (Figure 7). Interestingly, it was expressed at 
much lower levels at intermediate dorso-ventral areas of the neural tube likely 
corresponding to domains of class B roof plate-independent dorsal progenitors (Figure 
7; Helms and Johnson, 2003). It seems likely that Pax7 and/or other transcriptional 
factors may repress Nedd9 expression. Alternatively, Nedd9 levels would mainly 
depend on morphogenes originated in both the roof and the ventral plates which may 
not reach concentrations required for Nedd9 expression at this dorso-ventral level of the 
neural tube. Apart from that, Nedd9 expression was not found in the roof plate and in 
dP1 progenitor populations (Figure 7). Nedd9 was absent in the intermediate zone of 
the neural tube, defined as the region in between the ventricular and the mantle zones 
(Roztocil et al., 1997), in which neuronally committed progenitors presenting low 
levels of Tuj1 and high levels of Ngn2 mRNA are located (Figure 7). 
At E12.5, Nedd9 and Ngn2 mRNAs are homogeneously expressed  in the dorso-ventral 
axis of the neural tube. Nedd9 expression is restricted to the ventricular zone and Ngn2 
is mainly found in the intermediate zone (Figure 7).  
Interestingly and consistent with previous results, in the mesencephalic ventral 
midbrain, hypoglossal nucleus and the dorsal motor nucleus of the vagus nerve Nedd9 
expression is also downregulated in cells presenting high levels of Ngn2 mRNA 
expression and upon induction of Nurr1 expression, which identify neuronally 
committed progenitors (Figure 7; Zetterstrom et al., 1997; Wagner et al., 1999; Nieto et 
al., 2001; Wallen et al., 2001). Pool of Sox2+ progenitors of lateral domains to the 
ventral midbrain, characterized by their ngn1/ngn2 co-expression (our unpublished 
results) which will generate prospective occulomotor neurons express Nedd9 at much 
lower levels. 
We found a remarkable pattern of Nedd9 expression in the cerebellum at E12.5, since it 
was also present at lower levels in the Nurr1 weakly expressing cells of the mantle 
zone. Compatibility of Nedd9 expression with low levels of Nurr1 or Nurr1-like 
proteins was also found in gonads, cartilage primordium and gut epithelium but Nedd9 
was downregulated at the DRG when Nurr1-like expression was upregulated.    
From previous results, and considering our and others results on Nedd9 induction by 
retinoic acid (discussed in paper IV section of this introduction), it seems likely that 
Nurr1 and Nurr1-like proteins (known receptors for retinoic acid) may play a role of 
negative regulators of Nedd9 expression. 
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Fig.7: Nedd9 expression pattern in the neural tube. Schematic showing pattern of expression of 
Nedd9 (red), Ngn2 (green) or Nurr1 (blue) in trunk neural tube at E9.5 (A), E10.5 (B) and E12.5 (C) 
or mesencephalic ventral midbrain at E10.5 (D) and E12.5 (E). Color code pink denotes low levels 
of Nedd9 expression. Yellow: possible co-localization of Nedd9 and Ngn2.  
           
  
 Nedd9 was found to be expressed in Sox2+ progenitor cells of the retina, olfactory pit, 
gut epithelium and Rathke pouch. These evidences, together with the expression 
patterns described for the neural tube, suggest that Nedd9 is restricted to 
multipotent/oligopotent progenitors of diverse organs and it is therefore downregulated 
upon lineage commitment (Cai et al., 2002; Graham et al., 2003). 
Other tissues/organs which were found to express Nedd9 are the followings: heart (up 
to E10.5), respiratory epithelium, mesonephros, blood vessels (early developed limbs), 
meninges (hindbrain), urinary tract, and boundary cap. 
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